Disruption of only one interaction, between ICAM1 on sensitive AML cells and LFA-1 on T cells, is sufficient to increase AML resistance to killing both in vitro and in vivo by CD4IL10 cells, and in vitro by primary CD8+ T cells. This evidence concerns the gene CD8A and acute myeloid leukemia.